Chromocell Therapeutics Corp

New Filing
CIK: 0001919246·Pharmaceuticals·DELAWARE·Filed: Aug 6, 2024
Total Offering

$750,000

Amount Sold

$750,000

Investors

1

First Sale

Jul 24, 2024

Offering Details

Type
Debt, Security to be Acquired, Other: The convertible note is convertible into the company's common stock, par value $0.0001 per share.
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Francis Knuettel
Related Person
Eric Lang
Related Person
Todd Davis
Related Person
Ezra Friedberg
Related Person
Richard Malamut
Related Person
Chia-Lin Simmons
Related Person

Company

Pelthos Therapeutics Inc.

4400 Route 9 South

Freehold, NJ, 07728

(877) 265-8266

SEC Filing

0001919246-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free